Robert Bauer

Robert Bauer is an Executive Director of Operational Strategy at Precision with over 20 years of clinical trial operations experience from both the sponsor and CRO perspectives. He has led teams in the conduct of trials from Phase I through IV and has experience across a wide variety of trial designs. Bob has experience across many therapeutic areas some of which include rare diseases, oncology, depression, schizophrenia, and substance use disorders.

• Read: Clinical Trial Trends: Rare Cardiovascular

  Rare Diseases

  Clinical Trial Trends: Rare Cardiovascular

  Jul 17, ‘24 | 4 min read

  • 

    Robert Bauer

  Discover
• Read: Clinical Trial Trends: Rare Autoimmune

  Rare Diseases

  Clinical Trial Trends: Rare Autoimmune

  Jul 16, ‘24 | 5 min read

  • 

    Robert Bauer

  Discover
• Read: Clinical Trial Trends: Rare Oncology

  Rare Diseases

  Clinical Trial Trends: Rare Oncology

  Jul 16, ‘24 | 4 min read

  • 

    Robert Bauer

  Discover
• Read: Clinical Trial Trends: Rare Metabolic

  Rare Diseases

  Clinical Trial Trends: Rare Metabolic

  Jul 16, ‘24 | 4 min read

  • 

    Robert Bauer

  Discover
• Read: Clinical Trial Trends: Rare Pediatric

  Rare Diseases

  Clinical Trial Trends: Rare Pediatric

  Jun 13, ‘24 | 5 min read

  • 

    Robert Bauer

  Discover
• Read: Clinical Trial Trends: Rare CNS

  Clinical Trials

  Clinical Trial Trends: Rare CNS

  May 30, ‘24 | 3 min read

  • 

    Robert Bauer

  Discover
• Read: Unpacking FDA’s Draft Guidance on Psychedelic Research for Clinical Success

  Regulatory

  Unpacking FDA’s Draft Guidance on Psychedelic Research for Clinical Success

  Dec 13, ‘23 | 9 min read

  • 

    Robert Bauer

  Discover
• Read: Incorporating Decentralized Clinical Trial Strategies into CNS Studies

  Clinical Trials

  Incorporating Decentralized Clinical Trial Strategies into CNS Studies

  Aug 08, ‘23 | 4 min read

  • 

    Robert Bauer

  Discover

Loading...

You've reach the end Back to top